| 1 |
33961012 | Dasatinib inhibits proliferation of liver cancer cells, but activation of Akt/mTOR compromises dasatinib as a cancer drug. | 2021 Jul 5 |
1 |
| 2 |
33344441 | Dasatinib Inhibits Lung Cancer Cell Growth and Patient Derived Tumor Growth in Mice by Targeting LIMK1. | 2020 |
1 |
| 3 |
29803841 | The second generation tyrosine kinase inhibitor dasatinib induced eryptosis in human erythrocytes-An in vitro study. | 2018 Oct 1 |
1 |
| 4 |
29067110 | Growth inhibitory effect of the Src inhibitor dasatinib in combination with anticancer agents on uterine cervical adenocarcinoma cells. | 2017 Nov |
1 |
| 5 |
27126935 | [The combination of dasatinib and gefitinib enhances the killing effect of gefitinib on HCC827 lung cancer cells]. | 2016 May |
1 |
| 6 |
24918603 | Dasatinib accelerates valproic acid-induced acute myeloid leukemia cell death by regulation of differentiation capacity. | 2014 |
1 |
| 7 |
24976045 | Toward therapeutic effects evaluation of chronic myeloid leukemia drug: electrochemical platform for caspase-3 activity sensing. | 2014 Nov 15 |
1 |
| 8 |
23149070 | Dasatinib inhibits proliferation and induces apoptosis in the KASUMI-1 cell line bearing the t(8;21)(q22;q22) and the N822K c-kit mutation. | 2013 Feb |
1 |
| 9 |
23404469 | Antitumor effects of Dasatinib on laryngeal squamous cell carcinoma in vivo and in vitro. | 2013 Mar |
1 |
| 10 |
23588374 | Enhanced antitumor activity by the combination of dasatinib and combretastatin A-4 in vitro and in vivo. | 2013 Jun |
1 |
| 11 |
20406949 | Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition. | 2010 May |
1 |
| 12 |
19100678 | Combined BCR-ABL inhibition with lentiviral-delivered shRNA and dasatinib augments induction of apoptosis in Philadelphia-positive cells. | 2009 Feb |
1 |
| 13 |
18829496 | Characteristics of dasatinib- and imatinib-resistant chronic myelogenous leukemia cells. | 2008 Oct 1 |
1 |